Past Events

In this Online SPARK Europe Webinar "Telik Story: The rise and fall of a biotech company", Steve Schow, PhD will tell the 21-year tale of the birth, rise and demise of Telik, which at one point, was valued at ~$1.5 billon USD.

In this Online SPARK Europe Webinar "From PhD to CEO: why I want to make an impact in science or business", Dr. med. Verena Schöwel will share her journey from clinical practice to co-founding the biotech company MyoPax with Prof. Simone Spuler.

In this Online SPARK Europe Webinar "Financing of early stage start-ups", Dr Marcin Szumowski will talk about the funding of early stage companies (medtech and drug development) and the long term effects of early funding decisions

In this Online SPARK Europe Webinar "IVDR compliant multicentric clinical performance study", Karolina Kašparová will discover the essential role of compliance with the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in enhancing product quality.

In this Online SPARK Europe Webinar "Personalised Immunotherapy for Treatment of Rare Diseases", Dr. Regina Demlová will be exploring the vital role of personalised immunotherapy in the treatment of rare diseases.

In this Online SPARK Europe Webinar "Drug Development in Industry: Integrating Pharmacokinetics and Pharmacodynamics", Dr. Peter Florian will be exploring the vital role of Pharmacokinetics and Pharmacodynamics in driving Drug-development within the pharmaceutical industry.

In this Online SPARK Europe Webinar "How to WOW investors and get big $$$", Tami Reiss will share how to set the stage and present your research in a way that helps potential investors understand the value of what you’re proposing and the future monetary return potential.

In this online SPARK Europe Webinar Series, Heikki Pitkänen will discuss the regulatory landscape of medical software solutions.

In this Online SPARK Europe Webinar "What is drug repurposing and why is it relevant?", Hans Platteeuw will talk about the pros and cons of developing a new chemical entity as a drug, as well as the opportunities and challenges of repurposing and possible solutions.

SPARK Europe has joint forces for education on translational research and technology transfer! For the fifth time, European SPARK sites will host a joint webinar series during spring 2024.